Ken Fisher Ultragenyx Pharmaceutical Inc. Transaction History
Fisher Asset Management, LLC
- $247 Billion
- Q4 2024
A detailed history of Ken Fisher (Fisher Asset Management, LLC) transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Fisher Asset Management, LLC holds 265,189 shares of RARE stock, worth $12 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
265,189Holding current value
$12 Million% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding RARE
# of Institutions
328Shares Held
86MCall Options Held
520KPut Options Held
406K-
Vanguard Group Inc Valley Forge, PA9.95MShares$451 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$254 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA5.12MShares$232 Million0.91% of portfolio
-
Wellington Management Group LLP Boston, MA4.17MShares$189 Million0.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.07MShares$139 Million0.02% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $3.18B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...